AGL 40.00 No Change ▼ 0.00 (0%)
AIRLINK 129.00 Decreased By ▼ -0.53 (-0.41%)
BOP 6.76 Increased By ▲ 0.08 (1.2%)
CNERGY 4.50 Decreased By ▼ -0.13 (-2.81%)
DCL 8.70 Decreased By ▼ -0.24 (-2.68%)
DFML 41.00 Decreased By ▼ -0.69 (-1.66%)
DGKC 81.30 Decreased By ▼ -2.47 (-2.95%)
FCCL 32.68 Decreased By ▼ -0.09 (-0.27%)
FFBL 74.25 Decreased By ▼ -1.22 (-1.62%)
FFL 11.75 Increased By ▲ 0.28 (2.44%)
HUBC 110.03 Decreased By ▼ -0.52 (-0.47%)
HUMNL 13.80 Decreased By ▼ -0.76 (-5.22%)
KEL 5.29 Decreased By ▼ -0.10 (-1.86%)
KOSM 7.63 Decreased By ▼ -0.77 (-9.17%)
MLCF 38.35 Decreased By ▼ -1.44 (-3.62%)
NBP 63.70 Increased By ▲ 3.41 (5.66%)
OGDC 194.88 Decreased By ▼ -4.78 (-2.39%)
PAEL 25.75 Decreased By ▼ -0.90 (-3.38%)
PIBTL 7.37 Decreased By ▼ -0.29 (-3.79%)
PPL 155.74 Decreased By ▼ -2.18 (-1.38%)
PRL 25.70 Decreased By ▼ -1.03 (-3.85%)
PTC 17.56 Decreased By ▼ -0.90 (-4.88%)
SEARL 78.71 Decreased By ▼ -3.73 (-4.52%)
TELE 7.88 Decreased By ▼ -0.43 (-5.17%)
TOMCL 33.61 Decreased By ▼ -0.90 (-2.61%)
TPLP 8.41 Decreased By ▼ -0.65 (-7.17%)
TREET 16.26 Decreased By ▼ -1.21 (-6.93%)
TRG 58.60 Decreased By ▼ -2.72 (-4.44%)
UNITY 27.51 Increased By ▲ 0.08 (0.29%)
WTL 1.41 Increased By ▲ 0.03 (2.17%)
BR100 10,450 Increased By 43.4 (0.42%)
BR30 31,209 Decreased By -504.2 (-1.59%)
KSE100 97,798 Increased By 469.8 (0.48%)
KSE30 30,481 Increased By 288.3 (0.95%)

British scientists have applied for permission to edit the genes of human embryos in a series of experiments aimed at finding out more about the earliest stages of human development. Just months after Chinese scientists caused an international furore by saying they had genetically modified human embryos , Kathy Niakan, a stem cell scientist from London's Francis Crick Institute, has asked the British government's fertility regulator for a licence to carry out similar experiments.
In a statement about her application, which was made to the Human Fertilisation and Embryology Authority (HFEA), Niakan said she had no intention of genetically altering embryos for use in human reproduction, but aimed to deepen scientific understanding of how a healthy human embryo develops. "This knowledge may improve embryo development after in vitro fertilisation (IVF) and might provide better clinical treatments for infertility," she said in a statement, adding that any donated embryos would be used for research purposes only.
Scientists around the world are currently debating the potential future use of new genetic technology known as CRISPR-Cas9, which allows researchers to edit virtually any gene, including in human embryos. While the technology can enable scientists to find and change or replace genetic defects, critics say it also has the potential to create "designer babies" to order. A spokesman for the HFEA noted that British law bans genome editing of embryos for use in treatment, but allows it for research if done under an HFEA licence.
He confirmed that said the HFEA had received an application to use CRISPR-Cas9 in a licensed research project, and said it would be considered in due course. Sarah Chan at Edinburgh University's Usher Institute for Population Health Sciences and Informatics said the request for HFEA permission "should be cause for confidence, not concern".

Copyright Reuters, 2015

Comments

Comments are closed.